Understanding the cellular uptake of phosphopeptides

Cell Biochemistry and Biophysics

Volumn 31, Issue 2, 1999, Pages 129-140

  Allentoff, Alban J ^a   Mandiyan, Sreekala ^a   Liang, Hongbin ^a   Yuryev, Anton ^a   Vlattas, Isidoros ^a   Duelfer, Timothy ^a   Sytwu, Iou Iou ^a   Wennogle, Lawrence P ^a  

^a Novartis Pharma   (United States)

Author keywords

Cell penetration; Octanol water partitioning; Phosphopeptide; src homology domain (SH2)

Indexed keywords

ACETIC ANHYDRIDE; AMINE; CYCLOSPORIN; FLUORESCEIN; FLUORESCENT DYE; ION; OCTANOL; PHOSPHOPEPTIDE; PHOSPHOTYROSINE; WATER;

ACETYLATION; ANIMAL; ARTICLE; CELL LINE; CELL MEMBRANE; CHEMISTRY; ERYTHROCYTE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; METABOLISM; PHOSPHORYLATION; SRC HOMOLOGY DOMAIN;

ACETIC ANHYDRIDES; ACETYLATION; AMINES; ANIMALS; CELL LINE; CELL MEMBRANE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLOSPORINE; ERYTHROCYTES; FLUORESCEIN; FLUORESCENT DYES; HUMANS; IONS; OCTANOLS; PHOSPHOPEPTIDES; PHOSPHORYLATION; PHOSPHOTYROSINE; SRC HOMOLOGY DOMAINS; WATER;

EID: 0032620241     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02738168     Document Type: Article

References (30)

1. Davis, S. S. (1986) in Delivery Systems for Peptide Drugs (Davis, S. S., ed.), pp. 1-21, Plenum, New York.
2. Humphrey, M. J. (1986) in Delivery Systems for Peptide Drugs (Davis, S. S., ed.), pp. 139-151, Plenum, New York.
3. Kleinert, H. D., Rosenberg, S. H., Baker, W. R., Stein, H. H., Klinghofer, V., Barlow, J., et al. (1952) Discovery of a peptide-based renin inhibitor with oral bioavailability and efficacy. Science 257, 1940-1943.
4. Rosenberg, S. H., Kleinert, H. D., Stein, H. H., Martin, D. L., Chekal, M. A., Cohen, J., et al. (1991) Design of a well-absorbed renin inhibitor. J. Med. Chem. 34, 469-471.
5. Raeissi, S. and Audus, K. L. (1989) In-vitro characterization of blood-brain barrier permeability to delta sleep-inducing peptide. J. Pharm. Pharmacol. 41, 848-852.
6. Cefalu, W. T. and Pardridge, W. M. (1985) Restrictive transport of a lipid-soluble peptide (cyclosporin) through the blood-brain barrier. J. Neurochem. 45(6), 1954-1956.
7. Ziegler, K. and Seeberger, A. (1993) Carrier-mediated uptake of hydrophilic linear peptides with renin inhibitory activity into isolated rat liver cells. Biochem. Pharmacol. 45(4), 909-916.
8. Cambell, E. B. and Griffith, O. W. (1989) Glutathione monoethyl ester: high-performance liquid chromatographic analysis and direct preparation of the free base form. Anal. Biochem. 183, 21-25.
9. Wange, R. L., Isakov, N., Burke, T. R., Jr., Otaka, A., Roller, P. P., Watts, J. D., Aebersold, R., and Samelson, L. W. (1995) F2(Pmp)2-TAM zeta 3, a novel competitive inhibitor of the binding of ZA P-70 to the T-cell antigen receptor, blocks early T cell signaling. J. Biol. Chem. 270, 944-948.
10. Xiao, S., Rose, D. W., Sasaoka, T., Maegawa, H., Burke, T. R., Roller, P. P., Shoelson, S. E., and Olefsky, J. M. (1994) Syp (SH-PTP2) is a positive mediator of growth factor-stimulated mitogenic signal transduction. J. Biol. Chem. 269, 21,244-21,248.
11. Krise, J. P. and Stella, V. J. (1996) Prodrugs of phosphates, phosphonates, and phosphinates. Adv. Drug Deliv. Rev. 19, 287-310.
12. Friis, G. J. and Bundgaard, H. (1996) Pro-drugs pf phosphates and phosphonates: novel lipophilic α-acyloxyalkyl ester derivatives of phosphate-or phosphonate-containing drugs masking the negative charges of these groups. Eur. J. of Pharm. Sci. 4, 49-59.
13. Kole, H. K., Akamatsu, M., Ye, B., Yan, X., Barford, D., Roller, P. P., and Burke, T. R., Jr. (1995) Protein-tyrosine phosphatase inhibition by a peptide containing the phosphotyrosyl mimetic, L-O-malonyltyrosine. Biochem. and Biophys. Res. Commun. 209(3), 817-822.
14. Kelly M. A., Liang, H., Sytwu, L., Vlattas, I., Lyons, N. L., Bowen, B. R., and Wennogle, L. P. (1996) Characterization of SH2-ligand interactions via library affinity selection with mass spectrometric detection. Biochem. 35(36), 11747-11755.
15. Prochiantz, A. (1996) Getting hydrophilic compounds into cells: lessons from homeopeptides. Curr. Opinion in Neurobiol. 6, 629-634.
16. Stewart, J. M. and Young, J. D. (1984) in Solid phase peptide synthesis, second edition, p. 103, Pierce Chemical Company, Rockford, ILL.
17. Bender, W. W., Garan, H., and Berg, H. C. (1971) Proteins of the human erythrocyte membrane as modified by pronase. J. Mol. Biol. 58, 783-797.
18. Watts, M. E., Dennis, M. F., Jones, N. R., and Stratford, M. R. (1987) A comparison of the intracellular uptake and radiosensitization efficiency in different media of uncharged 2-nitroimidizoles of varying lipophilicity. Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 52(3), 359-370.
19. Collis, A. J. (1993) in Medicinal Chemistry; The Role of Organic Chemistry in Drug Research (Ganellin, C. R. and Roberts, S. M., eels.), pp. 61-82, Academic Press Inc, San Diego.
20. Bennett, C. F. (1997) Use of cationic lipid complexes for antisense oligonucleotide delivery. Applied Antisense Oligonucleotide Technology, in press.
21. Liu, Y., Mounkes, L. C., Liggitt, H. D., Brown, C. S., Solodin, I., Heath, T. D., and Debs, R. J. (1997) Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery. Nature Biotech. 15, 167-173.
22. Gordon, J. A. (1991) Use of vanadate as protein-phosphotyrosine phosphatase inhibitor. Methods Enzymol. 201, 477-482.
23. Potts, R. O. and Guy, R. H. (1993) The influence of molecular volume and hydrogen-bonding on peptide transport across epithelial membranes. Pharm. Res. 10(4), 635-636.
24. Hall, H., Williams, E. J., Moore, S. E., Walsh, F. S., Prochiantz, A., and Doherty, P. (1996) Inhibition of FGF-stimulated phosphatidyl-inositol hydrolysis and neurite outgrowth by a cell-membrane permeable phosphopeptide. Current Biology 6(5), 580-587.
25. Felgner, P. L., Holm, M., and Chan, H. (1989) Cationic liposome mediated transfection. Proc. West Pharmacol. Soc. 32, 115-121.
26. Nabel, E. G., Plautz, G. E., and Nabel, G. J. (1994) Recombinant growth factor gene expression in vascular cells in vivo. Ann. NY Acad. Sci. 714, 247-252.
27. Caplen, N. J., Kinrade, E., Sorgi, F., Gao, X., Gruenert, D., Geddes, D., Coutelle, C., Huang, L., Alton, E. W., and Williamson, R. (1995) In vitro liposome-mediated DNA transfection of epithelial cell lines using cationic liposome DC-Chol/DOPE. Gene Ther. 2, 603-613.
28. Aungst, B. J. (1993) Novel formulation strategies for improving oral bioavailablity of drugs with poor membrane permeation or presystemic metabolism. J. Pharm. Sci. 82(10), 979-987.
29. Leick, V. (1992) Chemotactic properties, cellular binding and uptake of peptides and peptide derivatives: studies with Tetrahymena thermophila. J. Cell Sci. 103, 565-570.
30. Abuelyaman, A. S., Hudig, D., Woodard, S. L., and Powers, J. C. (1994) Fluorescent derivatives of diphenyl[1-(N-peptidylamino)alkyl]phosphonate esters: synthesis and use in the inhibition and cellular localization of serine proteases. Bioconjugate Chem. 5, 400-405.